Vontobel Holding’s Lexaria Bioscience LEXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,013
Closed -$8.51K – 1549
2026
Q2
$8.51K Sell
1,013
-520
-34% -$5.64K ﹤0.01% 1469
2026
Q1
$17.9K Buy
+1,533
New +$16.7K ﹤0.01% 1185

Other funds holding LEXX

Vontobel Holding's LEXX Position: Q3 2026 in Review

Vontobel Holding sold out of Lexaria Bioscience (LEXX) in Q3 2026, closing a stake of 1,013 shares — an estimated $8.51K sold.

Vontobel Holding first reported a position in LEXX in Q1 2026 and held it in 2 quarters. The position peaked at $17.9K in Q1 2026. 15 funds tracked by Wall St. Rank hold LEXX as of Q3 2026.

  • Vontobel Holding reported no remaining Lexaria Bioscience position as of Q3 2026 after selling out during the quarter.
  • Vontobel Holding sold 1,013 Lexaria Bioscience shares in Q3 2026, an estimated $8.51K.
  • Vontobel Holding first reported a position in Lexaria Bioscience in Q1 2026 and held it in 2 quarters.
  • Vontobel Holding's Lexaria Bioscience position peaked at $17.9K in Q1 2026.
  • 15 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q3 2026.

Based on Vontobel Holding's 13F filing for Q3 2026, filed 16 Oct 2026.